Medical devices, healthcare technology and the business of care
510(k) clearance · K261869

Integrity Retractable Implant Inserter (6000127)

Anika Therapeutics, Inc. · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK261869

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for K261869, the Integrity Retractable Implant Inserter (6000127) submitted by Anika Therapeutics, Inc. of Bedford, Massachusetts. The submission is a Traditional 510(k) under 21 CFR 888.3040, Class II, product code MBI, orthopedic specialty. SESE means clearance to market, not premarket approval. The device is a sterile, single-use inserter that delivers a polyetheretherketone bone staple to fix the Integrity Implant to bone during rotator cuff repair, described in the summary as a line extension of the instruments in the Integrity Bone Staple Fixation System, cleared as K223860 on May 22, 2023.

The summary states non-clinical biocompatibility and mechanical performance testing supported substantial equivalence, with endotoxin testing under USP <85>, and that clinical testing was deemed unnecessary. The indications text in the enclosure concerns the Integrity Bone Staple Fixation System for fixation of soft tissue grafts or reinforcement meshes to bone during rotator cuff repairs. The record does not resolve discrepancies in the source, including differing received dates (June 4 versus August 13, 2026) and the regulation name given in the letter.

The record does not state whether the inserter itself carries a separate indication or how it is labeled for reuse, and no clinical outcome data are presented.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261869
Regulatory pathway
510(k) premarket notification
Product code
MBI
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.

Product code
MBI
FDA device class
2

FDA decision timeline

  1. K261869 received

    Application receipt date recorded by FDA.

  2. K261869 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MBI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Anika Therapeutics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Beford, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records